Following completion of this program, participants should be able to:

• • Diagnose and treat common Family Medicine problems using current and latest evidence based information
  • Prepare to pass the American Board of Family Medicine exam
  • Navigate the Knowledge Self-Assessment Modules (KSA) formerly S.A.M. required by the American Board of Family Medicine
    (Only available at live webinar conference)
  • Increase knowledge, competence, and performance through a comprehensive clinical review

Family Practitioners, General Practitioners, Internists, Physician Assistants, Nurse Practitioners, and Nurses

Lewis Katz School of Medicine at Temple University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Continuing Medical Education for physicians.

Lewis Katz School of Medicine at Temple University designates this live activity for a maximum of 58.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AAFP has reviewed 46th Annual Fall Family Medicine Review, and deemed it acceptable for AAFP credit. Term of approval is from 10/23/2022 to 10/28/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit approval includes the following session(s):

• • 58.00 Online Only, Live AAFP Prescribed Credit(s) – 46th Annual Fall Family Medicine Review
    • • • 8.00 Knowledge Self-Assessment, Live AAFP Prescribed Credit(s) – Knowledge Self-Assessment (KSA) Workshop on Diabetes
        • 8.00 Knowledge Self-Assessment, Live AAFP Prescribed Credit(s) – Knowledge Self-Assessment (KSA) Workshop on Asthma
        • 8.00 Knowledge Self-Assessment, Live AAFP Prescribed Credit(s) – Knowledge Self-Assessment (KSA) Workshop on Heart Disease

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 58.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To successfully complete this CME activity, a participant must complete the activity post-test with a score of 65% or higher, provide his or her ABIM ID number and date of birth (month and day only), and grant permission for the Lewis Katz School of Medicine at Temple University to transmit the data to the Accreditation Council for Continuing Medical Education (ACCME) for reporting of points to the ABIM. Physicians who do not know their six-digit ABIM ID number can look it up on ABIM’s website at https://www.abim.org/verify-physician.aspx

It is the policy of the Lewis Katz School of Medicine at Temple University, The Albert J. Finestone, M.D., Office for Continuing Medical Education that anyone in a position to control the content of a certified educational activity must disclose any financial relationships with ineligible companies within the prior 24 months. The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” Speakers must also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations. The Lewis Katz School of Medicine at Temple University has policies in place that will identify and mitigate all conflicts of interest prior to the educational activity. Detailed disclosure will be communicated to learners prior to the activity.

The faculty disclosed the following financial relationships with ineligible companies that were determined to be relevant to the content of this educational activity:

Lawrence Brent, MD
Stockholder: ChemoCentrix; Johnson & Johnson

Joshua Cooper, MD
Consultant: Abbott Medical; Boston Scientific; Johnson & Johnson; Medtronic; Zoll Medical

Avrum Gillespie, MD
Grant/Research funding: Vertex Pharmaceuticals

Rohit Gupta, MD
Consultant: MNK; Nabrivia Pharmaceutical

Mercedes Jacobson, MD
Consultant: LivaNova; Marinus
Grant/Research funding: Lilly; Marinus; UCB

Michael Kornberg, MD
Consultant: Biogen Idec; Genentech; Novartis; OptumRx; TG Therapeutics

Nathaniel Marchetti, DO
Consultant: Astra Zeneca
Grant/Research funding: CSA Medical (COPD Study); CSL Behring (IPF Study); Gala Therapeutics (COPD Study); Nuvaira (COPD Study); Sanofi, Department of Defense (Chill Study)

Aaron Mishkin, MD
Consultant: Takeda

Jack Mydlo, MD
Consultant: Genesis Biotechnology Scientific Advisory Board

Robert Pariser, MD
Grant/Research funding: Abbvie; Allergan; Arcutis; Argenx; Anaptysbio; Arrivo Bio; Boehringer Ingelheim; Biofrontera; Brickell; Cara Therapeutics; Castle; Celgene; Centocor; Dermata; Dermira; Eirion; Eli Lilly; Leo Pharma; Janssen; Mindera; Novartis; Palvella; Pfizer; Philips; Regeneron; Soligenix

Henry Parkman, MD
Consultant: Enterra; Evoke; Takeda
Grant/Research funding: Neurogastrix; Takeda; Vanda

Michel Pontari, MD
Grant/Research funding: Lipella (clinical trial)

Nishant Prasad, MD
Grant/Research funding: Gilead Sciences, Inc.

William Santoro, MD
Speakers Bureau: Indivior

All of the relevant financial relationships listed for these individuals have been mitigated.

None of the course directors, planners, reviewers, or managers for this educational activity have relevant financial relationships to disclose with ineligible companies.

This course does not receive any financial support from pharmaceutical or device companies.

For additional information or questions about this program, please contact:

Office for Continuing Medical Education
Lewis Katz School of Medicine at Temple University
Phone: 1-800-23-TUCME
Email: cme@temple.edu

If you experience any technical difficulties or have any questions about the course, please contact the CME office by email at cme@temple.edu, or by telephone at (215) 707-4787, toll-free at 1-800-23-TUCME.